发明名称 |
Use of fosfluridine tidoxil (FT) for the treatment of intraepithelial proliferative diseases |
摘要 |
The present invention is directed to the systemic administration of Fosfluridine Tidoxil, (5-fluorouridine)-5'-phosphoric acid (3-dodecylmercapto-2-decyloxy)propylester or a salt thereof, for the treatment of intraepithelial proliferative diseases such as actinic keratosis. The Fosfluridine Tidoxil can be systemically administered alone or in combination with topical treatment agents.
|
申请公布号 |
US2008014258(A1) |
申请公布日期 |
2008.01.17 |
申请号 |
US20060486376 |
申请日期 |
2006.07.14 |
申请人 |
HEIDELBERG PHARMA GMBH |
发明人 |
BOEHM ERWIN;KULKE MICHAEL;STOCKFLETH EGGERT |
分类号 |
A61K31/728;A61K9/22;A61K9/52;A61K31/198;A61K31/4745;A61K31/7072 |
主分类号 |
A61K31/728 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|